Spyre Therapeutics, Inc SYRE 深 沪
等待开盘 05-12 09:30:00 美东时间
77.31
+2.360
+3.15%
华盛通- 最 高78.80
- 今 开74.39
- 成交量 59.14万股
- 最 低 70.105
- 昨 收 74.95
- 总市值 0
- 52周最高 78.80
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 13.9301
- 委 比 60.00%
- 总股本 --
- 历史最高 78.80
- 量 比 1.08
- 振 幅 11.60%
- 历史最低 0.02
- 每 手 1
- 风险率 14.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
Earnings Summary: Spyre Therapeutics Q4
Spyre Therapeutics (NASDAQ:SYRE) announced its Q4 earnings on Thursday, Februar...
02-20 05:32
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-12-01 22:01
凯雷Q1坚定押注StandardAero(SARO.US) 清仓Robinhood(HOOD.US)
根据美国证券交易委员会(SEC)披露，全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2025年3月31日的第一季度持仓报告(13F...
2025-05-16 17:23
Wedbush Initiates Spyre Therapeutics at Outperform With $45 Price Target
06:24 AM EDT, 09/04/2024 (MT Newswires) -- Spyre Therapeutics (SYRE) has an average buy rating and a price target range of $40 to $54, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia a...
2024-09-04 18:24
